FEATURED/ARCHIVES (02/05/24)
Coenzyme Q10 and Neuropsychiatric and Neurological Disorders: Relevance for Schizophrenia · December 2018
Abstracts
Nutritional Neuroscience
Health Outcomes among Patients Diagnosed with Schizophrenia in the US Veterans Health Administration Population Who Transitioned from Once-Monthly to Once-Every-3-Month Paliperidone Palmitate: An Observational Retrospective Analysis · August 2019
Abstracts
Advances in Therapy
Prevalence of Psychosis in Tuberculosis Patients and Their Nontuberculosis Family Contacts in a Multidrug Treatment-Resistant Treatment Center in Nigeria · May 2015
Abstracts
General Hospital Psychiatry
Lurasidone Augmentation of Clozapine in Refractory Schizophrenia: A Case Series · March 2023
Abstracts
Journal of Clinical Psychopharmacology
Pro-Inflammatory Cytokine Levels Are Elevated in Female Patients with Schizophrenia Treated with Clozapine · January 2022
Abstracts
Psychopharmacology
Antihistamine May Decrease Schizophrenia Symptoms (Meetings-Events) · October 2013
Abstracts (Summaries)
Medscape>European College of Neuropsychopharmacology
A Cross-Sectional Study of Vitamin D Deficiency among Immigrants and Norwegians with Psychosis Compared to the General Population · April 2010
Abstracts
Journal of Clinical Psychiatry
Maintenance Treatment with Long-Acting Injectable Risperidone in First-Episode Schizophrenia: A Randomized Effectiveness Study · August 2012
Abstracts
Journal of Clinical Psychiatry
Bullying Victimisation and Paranoid Ideation in People at Ultra High Risk for Psychosis · September 2015
Abstracts
Schizophrenia Research
Prolactin-Elevating Antipsychotics and the Risk of Endometrial Cancer · June 2017
Abstracts
Journal of Clinical Psychiatry
Randomised Controlled Trial of Metacognitive Training Compared with Psychoeducation in Patients with Schizophrenia Spectrum Disorders: Effects on Insight (Meetings-Events) · May 2020
Abstracts
Schizophrenia Bulletin
Relapse Prevention in Schizophrenia and Schizoaffective Disorder with Risperidone Long-Acting Injectable versus Quetiapine: Randomized, Long-Term, Open-Label, Clinical Trial Results (ConstaTRE) (Meetings-Events) · March 2009
Abstracts
European Psychiatry
Reducing Violence Risk in Persons with Schizophrenia: Olanzapine versus Risperidone · December 2004
Abstracts
Journal of Clinical Psychiatry
Bupropion Increases Rate of Smoking Abstinence in Smokers with Schizophrenia: A Systematic Review and Meta-Analysis of Randomised Trial Data (Meetings-Events) · March 2009
Abstracts
European Psychiatry
Problem Gambling Associated with Aripiprazole: A Nested Case-Control Study in a First-Episode Psychosis Program · March 2021
Abstracts
CNS Drugs
The Effect of Cariprazine on Hostility Associated with Schizophrenia: Post Hoc Analyses from 3 Randomized Controlled Trials · January 2016
Abstracts
Journal of Clinical Psychiatry
Lower IQ Linked to Risk for Future Schizophrenia (Meetings-Events) · April 2012
Abstracts (Summaries)
Medscape>Schizophrenia International Research Society
Depression in Schizophrenia: Comparison of First- and Second-Generation Antipsychotic Drugs · December 2007
Abstracts
Schizophrenia Research
Discontinuation and Relapse with Paliperidone Palmitate Three-Monthly for Maintenance of Schizophrenia: Two Year Follow-Up of Use in Clinical Practice · April 2021
Abstracts
Journal of Psychopharmacology
Neurocognitive Effects of Agomelatine Treatment in Schizophrenia Patients Suffering from Comorbid Depression: Results from the AGOPSYCH Study · August 2018
Abstracts
Journal of Clinical Psychopharmacology